Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Choosing between cash back and points for travel can impact your rewards. Explore which option suits your travel style!
27,012 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
A surprisingly strong first quarter has some investors asking if Stellantis can shake off years of underperformance. ...
Amazon plans an unprecedented AI data-center buildout, with a $200 billion capex target for 2026. This article unpack...
AI stocks have run hot, but some Wall Street analysts see big downside. Here are two names in the artificial intellig...
A bigger 2027 COLA might sound like easy money for Social Security beneficiaries. But the real impact goes beyond big...
Lands' End is at a crossroads as it approaches 2025 earnings. This guide breaks down what to watch, how to model pote...
A large fund sold about $17 million in ZoomInfo shares while the company posted slim revenue growth. This article bre...
As investors look toward talen (tln) 2025 earnings, the Q4 transcript becomes the compass for revenue, margins, and g...
A looming recession can rattle nerves, but retirees don’t have to panic. Here are three clear moves to shore up cash,...
Geopolitics just accelerated volatility in energy markets. The rejection of a ceasefire proposal by iran has traders ...
A once-niche software play may be quietly building a full AI-driven financial platform. This software stock could del...
Box and DocuSign sit at different corners of the SaaS world. This analysis shows how quarterly revenue patterns illum...